前列腺癌筛查——以MRI向前迈进
本文综述MRI整合入前列腺癌筛查路径的文献与指南,提出优化标准:需明确MRI使用场景,核心是患者选择与MRI靶向活检;高危男性应采用筛查专用MRI方案并建立准确性水平与判读标准;优化阅读需自动化数据采集、图像质量监测、后处理、放射科医师认证及深度学习计算机辅助软件;MRI应整合入多步诊断路径,并配备质量保证且具成本效益的基础设施。
要点
- 人群前列腺癌筛查是前列腺MRI的新适应证,可检出高风险癌并减少活检需求及相关伤害。
- 优化筛查用MRI需重新定义MRI方案,建立准确性、可靠性及判读标准。
- 优化阅读包括后处理、图像质量、放射科医师认证及深度学习计算机辅助软件。
核心结论
- MRI用于前列腺癌筛查路径可带来实质性诊断获益,通过权衡其优势、局限与安全性关切并整合入多步诊断路径,临床医生可在改善结局的同时尽量减少对筛查参与者的伤害。
研究设计与样本
- 本文为综述,回顾现有研究、临床指南与专家意见,采用综合筛查原则提出将MRI整合入诊断路径的建议,原文未报告系统检索范围与纳入文献数量。
诊断标准与关键数值
- 原文未报告具体的敏感度、特异度、AUC、阈值或分级标准数值。
临床应用与阅片要点
- 对风险高于平均水平男性,使用筛查专用MRI方案并建立准确性水平与判读标准。
- 通过自动化数据采集、图像质量监测、后处理、放射科医师认证与深度学习计算机辅助软件优化判读。
- 将MRI整合入多步诊断路径,并配备质量保证且具成本效益、确保社区范围影像可及的基础设施。
- 作者认为优化关键在于患者选择与MRI靶向活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To comprehensively review the literature on the integration of MRI as a diagnostic tool in prostate cancer screening and offer practical recommendations for optimising its use.
METHODS: Existing research studies, clinical guidelines and expert opinions were reviewed to support the optimisation standards for MRI use in screening. Consolidated screening principles were used to make appropriate recommendations regarding the integration of MRI into the diagnostic pathway.
RESULTS: To strike a balance between the potential benefits of early detection on mortality and minimising the harm of over-diagnosing indolent cancers, it is necessary to have a clear understanding of the context of MRI use. The key to optimisation is patient selections and MRI-targeted biopsies. For men at higher-than-average risk, it is essential to use screening-specific MRI protocols and establish accuracy levels and interpretation criteria. Optimisation of readings by the automation of data acquisition, image quality monitoring, post-processing, radiologist certification and deep-learning computer-aided software is needed. The optimal utilisation of MRI involves its integration into a multistep diagnostic pathway, supported by a quality-assured and cost-effective infrastructure that ensures community-wide access to imaging.
CONCLUSION: MRI in the prostate cancer screening pathway can bring substantial diagnostic benefits. By carefully considering its advantages, limitations and safety concerns and integrating it into a multistep diagnostic pathway, clinicians can improve outcomes while minimising harm to screening participants.
CLINICAL RELEVANCE STATEMENT: The manuscript discusses the role of MRI in prostate cancer screening, highlighting its potential to improve accuracy and reduce overdiagnosis. It emphasises the importance of optimising protocols and integrating MRI into a multistep diagnostic pathway for successfully delivering screening benefits.
KEY POINTS: • Population screening for prostate cancer is a new indication for prostate MRI that allows the detection of high-risk cancers while reducing the need for biopsies and associated harm. • To optimise prostate cancer screening using MRI, it is essential to redefine MRI protocols; establish accuracy levels, reliability and interpretation criteria; and optimise reading (including post-processing, image quality, radiologist certification, and deep-learning computer-aided software). • The optimal utilisation of MRI for prostate cancer screening would involve its integration into a multistep diagnostic pathway, supported by a quality-assured and cost-effective infrastructure that ensures community-wide access to imaging.
引用
- Padhani, Schoots. Prostate cancer screening-stepping forward with MRI. Eur Radiol. 2023. PMID: 37154952. doi:10.1007/s00330-023-09673-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。